NCT00582504: A trial that was reported late by U.S. Army Medical Research and Development Command
This trial has reported, although it was 166 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT00582504 |
|---|---|
| Title | A Phase 2 Open-Label, Safety and Immunogenicity Study of a Single Dose of Venezuelan Equine Encephalomyelitis Vaccine, Live, Attenuated, Dried, TC-83, NDBR-102, as Primary Immunization in Healthy Adults At Risk for Exposure to Virulent Venezuelan Equine Encephalomyelitis Virus |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Sept. 30, 2007 |
| Completion date | Dec. 31, 2021 |
| Required reporting date | Dec. 31, 2022, midnight |
| Actual reporting date | June 15, 2023 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | 166 |